Bayer Launches Medrad Mark 7 Arterion® Injection System

Tarrytown, June 20, 2012 – Bayer HealthCare’s Radiology and Interventional unit has launched the new Mark 7 Arterion® Injection System, the latest in the Medrad Mark series of angiographic injectors. The first Medrad Mark injector was introduced for use in angiograms more than 40 years ago. “The Mark 7 Arterion system's user interface facilitates the setting up and performing of contrast injections," said Robyn Reising, of Decatur Memorial Hospital where the very first Arterion system was installed in the U.S. "The front-load system shall streamline the pre and post-procedure activities and the clear syringe allows us to monitor the purging of air." In 1964, the first Medrad injector – called the Heilman-Wholey Injector – was the first flow-controlled angiographic injector commercialized in the U.S. The Arterion is the seventh in the Mark series for angiography. Find more information at www.bayerhealthcare.com.